Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-579939
Filing Date
2016-05-05
Accepted
2016-05-05 16:20:01
Documents
41
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d191733d10q.htm 10-Q 397818
2 EX-10.1 d191733dex101.htm EX-10.1 52726
3 EX-31.1 d191733dex311.htm EX-31.1 8997
4 EX-31.2 d191733dex312.htm EX-31.2 9305
5 EX-32.1 d191733dex321.htm EX-32.1 5178
  Complete submission text file 0001193125-16-579939.txt   2179572

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hrtx-20160331.xml EX-101.INS 345238
7 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20160331.xsd EX-101.SCH 24604
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20160331_cal.xml EX-101.CAL 20959
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20160331_def.xml EX-101.DEF 162538
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20160331_lab.xml EX-101.LAB 163069
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20160331_pre.xml EX-101.PRE 175469
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 161624073
SIC: 2834 Pharmaceutical Preparations